More on ESLA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Estrella Immunopharma (NQ:ESLA)
Delayed: 0.68 +0.01 (1.49%)
Prev. Close $0.67  
Open$0.70 
52 Wk High$ 
52 Wk Low$ 
Day High$0.72 
Day Low$0.67 
P/E N/A  
EPS$ 
Volume10,068 

Friends, Peers and Foes (?): ESLAW (more...)

Aug 26, 2026 07:24 PM Form 4 Estrella Immunopharma, For: Aug 25 Filed by: Liu Cheng
Aug 25, 2026 09:56 PM Form 4 Estrella Immunopharma, For: Aug 18 Filed by: Xu Jiandong
Aug 21, 2026 05:00 PM Form 8-K Estrella Immunopharma, For: Aug 17
Aug 14, 2026 10:12 AM Form SCHEDULE 13G/A Estrella Immunopharma, Filed by: ARMISTICE CAPITAL, LLC
Aug 13, 2026 05:02 PM Form 10-Q Estrella Immunopharma, For: Jun 30
Aug 11, 2026 08:01 AM Estrella Immunopharma adds fourth site to lymphoma trial
Aug 11, 2026 08:00 AM Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Aug 3, 2026 08:03 AM Estrella adds Oregon Health & Science University to lymphoma trial
Aug 3, 2026 08:00 AM Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Jul 29, 2026 08:01 AM Estrella Immunopharma adds Baylor site to lymphoma trial
View All Articles

Entities mentioned with ESLA

View All Entities